annual D&A:
$3.18M+$169.00K(+5.62%)Summary
- As of today (July 3, 2025), CLDX annual depreciation & amortization is $3.18 million, with the most recent change of +$169.00 thousand (+5.62%) on December 31, 2024.
- During the last 3 years, CLDX annual D&A has risen by +$109.00 thousand (+3.55%).
- CLDX annual D&A is now -45.79% below its all-time high of $5.86 million, reached on December 31, 2010.
Performance
CLDX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$867.00K+$48.00K(+5.86%)Summary
- As of today (July 3, 2025), CLDX quarterly depreciation & amortization is $867.00 thousand, with the most recent change of +$48.00 thousand (+5.86%) on March 31, 2025.
- Over the past year, CLDX quarterly D&A has increased by +$92.00 thousand (+11.87%).
- CLDX quarterly D&A is now -64.29% below its all-time high of $2.43 million, reached on March 31, 2010.
Performance
CLDX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$3.27M+$92.00K(+2.90%)Summary
- As of today (July 3, 2025), CLDX TTM depreciation & amortization is $3.27 million, with the most recent change of +$92.00 thousand (+2.90%) on March 31, 2025.
- Over the past year, CLDX TTM D&A has increased by +$212.00 thousand (+6.93%).
- CLDX TTM D&A is now -46.75% below its all-time high of $6.14 million, reached on September 30, 2010.
Performance
CLDX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CLDX Depreciation and amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +5.6% | +11.9% | +6.9% |
3 y3 years | +3.5% | +6.9% | +5.3% |
5 y5 years | -34.6% | -25.6% | -29.9% |
CLDX Depreciation and amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +9.7% | at high | +29.2% | at high | +16.3% |
5 y | 5-year | -34.6% | +9.7% | -24.5% | +29.2% | -29.9% | +16.3% |
alltime | all time | -45.8% | +694.3% | -64.3% | +240.0% | -46.8% | >+9999.0% |
CLDX Depreciation and amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $867.00K(+5.9%) | $3.27M(+2.9%) |
Dec 2024 | $3.18M(+5.6%) | $819.00K(+4.2%) | $3.18M(+1.9%) |
Sep 2024 | - | $786.00K(-1.4%) | $3.12M(+0.6%) |
Jun 2024 | - | $797.00K(+2.8%) | $3.10M(+1.3%) |
Mar 2024 | - | $775.00K(+2.1%) | $3.06M(+1.6%) |
Dec 2023 | $3.01M(+3.9%) | $759.00K(-1.0%) | $3.01M(+2.9%) |
Sep 2023 | - | $767.00K(+1.5%) | $2.92M(+3.4%) |
Jun 2023 | - | $756.00K(+4.1%) | $2.83M(+0.5%) |
Mar 2023 | - | $726.00K(+7.9%) | $2.81M(-2.9%) |
Dec 2022 | $2.90M(-5.6%) | $673.00K(+0.3%) | $2.90M(-3.5%) |
Sep 2022 | - | $671.00K(-9.4%) | $3.00M(-2.6%) |
Jun 2022 | - | $741.00K(-8.6%) | $3.08M(-0.7%) |
Mar 2022 | - | $811.00K(+4.4%) | $3.10M(+1.2%) |
Dec 2021 | $3.07M(-21.9%) | $777.00K(+3.3%) | $3.07M(+0.7%) |
Sep 2021 | - | $752.00K(-1.6%) | $3.05M(-3.5%) |
Jun 2021 | - | $764.00K(-1.4%) | $3.15M(-10.9%) |
Mar 2021 | - | $775.00K(+2.6%) | $3.54M(-9.9%) |
Dec 2020 | $3.93M(-19.1%) | $755.00K(-12.3%) | $3.93M(-9.0%) |
Sep 2020 | - | $861.00K(-25.0%) | $4.32M(-7.4%) |
Jun 2020 | - | $1.15M(-1.5%) | $4.67M(-0.1%) |
Mar 2020 | - | $1.17M(+1.7%) | $4.67M(-3.8%) |
Dec 2019 | $4.86M(+27.8%) | $1.15M(-5.2%) | $4.86M(+9.6%) |
Sep 2019 | - | $1.21M(+4.8%) | $4.43M(+9.2%) |
Jun 2019 | - | $1.15M(-14.7%) | $4.06M(+4.1%) |
Mar 2019 | - | $1.35M(+87.5%) | $3.90M(+2.6%) |
Dec 2018 | $3.80M(-28.4%) | $721.00K(-13.7%) | $3.80M(-12.1%) |
Sep 2018 | - | $835.00K(-15.9%) | $4.33M(-8.7%) |
Jun 2018 | - | $993.00K(-20.7%) | $4.74M(-4.7%) |
Mar 2018 | - | $1.25M(+0.5%) | $4.97M(-6.4%) |
Dec 2017 | $5.31M(+29.8%) | $1.25M(-0.2%) | $5.31M(+0.9%) |
Sep 2017 | - | $1.25M(+2.0%) | $5.26M(+5.9%) |
Jun 2017 | - | $1.23M(-23.0%) | $4.97M(+6.0%) |
Mar 2017 | - | $1.59M(+32.8%) | $4.69M(+14.5%) |
Dec 2016 | $4.09M(+2.0%) | $1.20M(+25.5%) | $4.09M(+2.4%) |
Sep 2016 | - | $954.00K(+0.8%) | $4.00M(-1.6%) |
Jun 2016 | - | $946.00K(-4.9%) | $4.06M(-0.5%) |
Mar 2016 | - | $995.00K(-9.5%) | $4.08M(+1.7%) |
Dec 2015 | $4.01M(+17.9%) | $1.10M(+7.8%) | $4.01M(+5.9%) |
Sep 2015 | - | $1.02M(+5.6%) | $3.79M(+4.5%) |
Jun 2015 | - | $966.00K(+4.4%) | $3.62M(+3.7%) |
Mar 2015 | - | $925.00K(+5.5%) | $3.49M(+2.7%) |
Dec 2014 | $3.40M(+15.5%) | $877.00K(+2.5%) | $3.40M(+3.5%) |
Sep 2014 | - | $856.00K(+2.4%) | $3.29M(+3.9%) |
Jun 2014 | - | $836.00K(+0.5%) | $3.16M(+3.5%) |
Mar 2014 | - | $832.00K(+9.0%) | $3.06M(+3.8%) |
Dec 2013 | $2.94M(-6.1%) | $763.00K(+4.2%) | $2.94M(+1.3%) |
Sep 2013 | - | $732.00K(+0.4%) | $2.91M(-0.8%) |
Jun 2013 | - | $729.00K(+1.1%) | $2.93M(-3.0%) |
Mar 2013 | - | $721.00K(-0.6%) | $3.02M(-3.6%) |
Dec 2012 | $3.14M(-24.6%) | $725.00K(-4.1%) | $3.14M(-3.6%) |
Sep 2012 | - | $756.00K(-7.9%) | $3.25M(-12.5%) |
Jun 2012 | - | $821.00K(-1.7%) | $3.72M(-5.8%) |
Mar 2012 | - | $835.00K(-0.9%) | $3.95M(-5.0%) |
Dec 2011 | $4.16M(-29.0%) | $843.00K(-31.0%) | $4.16M(-3.9%) |
Sep 2011 | - | $1.22M(+16.3%) | $4.33M(+3.8%) |
Jun 2011 | - | $1.05M(+0.6%) | $4.17M(-6.9%) |
Mar 2011 | - | $1.04M(+3.2%) | $4.48M(-23.6%) |
Dec 2010 | $5.86M(+65.9%) | $1.01M(-4.6%) | $5.86M(-4.5%) |
Sep 2010 | - | $1.06M(-21.8%) | $6.14M(+6.0%) |
Jun 2010 | - | $1.36M(-44.1%) | $5.79M(+11.8%) |
Mar 2010 | - | $2.43M(+88.1%) | $5.18M(+46.6%) |
Dec 2009 | $3.53M(+39.2%) | $1.29M(+80.8%) | $3.53M(+28.4%) |
Sep 2009 | - | $714.00K(-4.3%) | $2.75M(-3.5%) |
Jun 2009 | - | $746.00K(-4.5%) | $2.85M(-2.3%) |
Mar 2009 | - | $781.00K(+53.3%) | $2.92M(+14.9%) |
Dec 2008 | $2.54M(+206.7%) | $509.40K(-37.4%) | $2.54M(+14.1%) |
Sep 2008 | - | $813.40K(+0.2%) | $2.22M(+176.0%) |
Jun 2008 | - | $812.10K(+102.0%) | $805.40K(-21.0%) |
Mar 2008 | - | $402.00K(+105.7%) | $1.02M(+23.3%) |
Dec 2007 | $827.10K | $195.40K(-132.3%) | $827.10K(+6464.3%) |
Sep 2007 | - | -$604.10K(-158.8%) | $12.60K(-98.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2007 | - | $1.03M(+391.0%) | $1.16M(+86.2%) |
Mar 2007 | - | $209.10K(-133.8%) | $622.50K(-29.8%) |
Dec 2006 | $886.50K(-58.4%) | -$619.10K(-214.2%) | $886.50K(-58.4%) |
Sep 2006 | - | $542.30K(+10.6%) | $2.13M(-1.6%) |
Jun 2006 | - | $490.20K(+3.6%) | $2.16M(-4.3%) |
Mar 2006 | - | $473.10K(-24.2%) | $2.26M(+6.1%) |
Dec 2005 | $2.13M(+24.1%) | $624.00K(+8.3%) | $2.13M(+8.1%) |
Sep 2005 | - | $576.40K(-1.8%) | $1.97M(+8.9%) |
Jun 2005 | - | $586.90K(+71.4%) | $1.81M(+10.5%) |
Mar 2005 | - | $342.40K(-26.2%) | $1.64M(-4.6%) |
Dec 2004 | $1.72M(+12.4%) | $464.10K(+11.6%) | $1.72M(+19.2%) |
Sep 2004 | - | $416.00K(+0.4%) | $1.44M(-2.3%) |
Jun 2004 | - | $414.40K(-1.7%) | $1.47M(-2.7%) |
Mar 2004 | - | $421.70K(+125.1%) | $1.51M(-0.9%) |
Dec 2003 | $1.53M(-5.9%) | $187.30K(-58.4%) | $1.53M(-12.0%) |
Sep 2003 | - | $449.80K(-1.1%) | $1.73M(+3.1%) |
Jun 2003 | - | $454.90K(+4.6%) | $1.68M(+3.3%) |
Mar 2003 | - | $435.10K(+10.2%) | $1.63M(+0.4%) |
Dec 2002 | $1.62M(-28.1%) | $394.80K(-0.5%) | $1.62M(-11.4%) |
Sep 2002 | - | $396.90K(-1.0%) | $1.83M(-7.4%) |
Jun 2002 | - | $401.10K(-6.6%) | $1.98M(-7.8%) |
Mar 2002 | - | $429.30K(-28.8%) | $2.14M(-5.1%) |
Dec 2001 | $2.26M(+72.2%) | $603.00K(+11.2%) | $2.26M(+10.4%) |
Sep 2001 | - | $542.20K(-4.5%) | $2.05M(+13.5%) |
Jun 2001 | - | $567.70K(+4.3%) | $1.80M(+17.6%) |
Mar 2001 | - | $544.40K(+39.2%) | $1.53M(+16.9%) |
Dec 2000 | $1.31M(-34.1%) | $391.00K(+31.0%) | $1.31M(+8.5%) |
Sep 2000 | - | $298.50K(-0.1%) | $1.21M(-20.0%) |
Jun 2000 | - | $298.70K(-7.4%) | $1.51M(-11.8%) |
Mar 2000 | - | $322.60K(+11.8%) | $1.71M(-13.9%) |
Dec 1999 | $1.99M(+98.9%) | $288.60K(-51.9%) | $1.99M(-13.5%) |
Sep 1999 | - | $600.00K(+20.0%) | $2.30M(+21.1%) |
Jun 1999 | - | $500.00K(-16.7%) | $1.90M(+26.7%) |
Mar 1999 | - | $600.00K(0.0%) | $1.50M(+50.0%) |
Dec 1998 | $1.00M(+150.0%) | $600.00K(+200.0%) | $1.00M(+100.0%) |
Sep 1998 | - | $200.00K(+100.0%) | $500.00K(+25.0%) |
Jun 1998 | - | $100.00K(0.0%) | $400.00K(0.0%) |
Mar 1998 | - | $100.00K(0.0%) | $400.00K(0.0%) |
Dec 1997 | $400.00K(-20.0%) | $100.00K(0.0%) | $400.00K(0.0%) |
Sep 1997 | - | $100.00K(0.0%) | $400.00K(-20.0%) |
Jun 1997 | - | $100.00K(0.0%) | $500.00K(0.0%) |
Mar 1997 | - | $100.00K(0.0%) | $500.00K(0.0%) |
Dec 1996 | $500.00K(-28.6%) | $100.00K(-50.0%) | $500.00K(-28.6%) |
Sep 1996 | - | $200.00K(+100.0%) | $700.00K(+16.7%) |
Jun 1996 | - | $100.00K(0.0%) | $600.00K(0.0%) |
Mar 1996 | - | $100.00K(-66.7%) | $600.00K(-14.3%) |
Dec 1995 | $700.00K(-12.5%) | $300.00K(+200.0%) | $700.00K(+16.7%) |
Sep 1995 | - | $100.00K(0.0%) | $600.00K(-14.3%) |
Jun 1995 | - | $100.00K(-50.0%) | $700.00K(-12.5%) |
Mar 1995 | - | $200.00K(0.0%) | $800.00K(0.0%) |
Dec 1994 | $800.00K(-11.1%) | $200.00K(0.0%) | $800.00K(-20.0%) |
Sep 1994 | - | $200.00K(0.0%) | $1.00M(0.0%) |
Jun 1994 | - | $200.00K(0.0%) | $1.00M(+11.1%) |
Mar 1994 | - | $200.00K(-50.0%) | $900.00K(0.0%) |
Dec 1993 | $900.00K(+50.0%) | $400.00K(+100.0%) | $900.00K(+80.0%) |
Sep 1993 | - | $200.00K(+100.0%) | $500.00K(-16.7%) |
Jun 1993 | - | $100.00K(-50.0%) | $600.00K(0.0%) |
Mar 1993 | - | $200.00K(-33.3%) | $600.00K(-14.3%) |
Dec 1992 | $600.00K(0.0%) | - | - |
Oct 1992 | - | $300.00K(+200.0%) | $700.00K(+16.7%) |
Jul 1992 | - | $100.00K(-50.0%) | $600.00K(0.0%) |
Apr 1992 | - | $200.00K(+100.0%) | $600.00K(0.0%) |
Apr 1992 | $600.00K(0.0%) | - | - |
Jan 1992 | - | $100.00K(-50.0%) | $600.00K(0.0%) |
Oct 1991 | - | $200.00K(+100.0%) | $600.00K(0.0%) |
Jul 1991 | - | $100.00K(-50.0%) | $600.00K(0.0%) |
Apr 1991 | $600.00K(+20.0%) | $200.00K(+100.0%) | $600.00K(+50.0%) |
Jan 1991 | - | $100.00K(-50.0%) | $400.00K(+33.3%) |
Oct 1990 | - | $200.00K(+100.0%) | $300.00K(+200.0%) |
Jul 1990 | - | $100.00K | $100.00K |
Apr 1990 | $500.00K | - | - |
FAQ
- What is Celldex Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Celldex Therapeutics?
- What is Celldex Therapeutics annual D&A year-on-year change?
- What is Celldex Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly D&A year-on-year change?
- What is Celldex Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Celldex Therapeutics?
- What is Celldex Therapeutics TTM D&A year-on-year change?
What is Celldex Therapeutics annual depreciation & amortization?
The current annual D&A of CLDX is $3.18M
What is the all time high annual D&A for Celldex Therapeutics?
Celldex Therapeutics all-time high annual depreciation & amortization is $5.86M
What is Celldex Therapeutics annual D&A year-on-year change?
Over the past year, CLDX annual depreciation & amortization has changed by +$169.00K (+5.62%)
What is Celldex Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of CLDX is $867.00K
What is the all time high quarterly D&A for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly depreciation & amortization is $2.43M
What is Celldex Therapeutics quarterly D&A year-on-year change?
Over the past year, CLDX quarterly depreciation & amortization has changed by +$92.00K (+11.87%)
What is Celldex Therapeutics TTM depreciation & amortization?
The current TTM D&A of CLDX is $3.27M
What is the all time high TTM D&A for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM depreciation & amortization is $6.14M
What is Celldex Therapeutics TTM D&A year-on-year change?
Over the past year, CLDX TTM depreciation & amortization has changed by +$212.00K (+6.93%)